TipRanks
Go Ultimate55% OFF

Hansa Biopharma AB (HNSAN) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

HNSAN Analyst Ratings

There are no analyst ratings in the last 3 months.

HNSAN Stock 12 Month Forecast

There are no analyst price targets in the last 3 months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for MX:HNSAN
Price TargetFollowArticle
H.C. WainwrightMXN 192.07buy―Reiterated07/24/26
WedbushMXN 128.67buy―Initiated01/07/26
Leerink PartnersMXN 190.21buy―Initiated11/26/25
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Hansa Biopharma AB

3 Months
Douglas Tsao
Douglas TsaoH.C. Wainwright
Success Rate11/24 ratings generated profit
46%
Average Return
+5.18%

Copying Douglas Tsao's trades and holding each position for 3 Months would result in 45.83% of your transactions generating a profit, with an average return of +5.18% per trade.

1 Year
Douglas Tsao
Douglas TsaoH.C. Wainwright
Success Rate13/24 ratings generated profit
54%
Average Return
+6.67%

Copying Douglas Tsao's trades and holding each position for 1 Year would result in 54.17% of your transactions generating a profit, with an average return of +6.67% per trade.

2 Years
Douglas Tsao
Douglas TsaoH.C. Wainwright
Success Rate16/24 ratings generated profit
67%
Average Return
+14.27%

Copying Douglas Tsao's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +14.27% per trade.

HNSAN Analyst Recommendation Trends

02468Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for HNSAN
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy44210
Buy00000
Hold00000
Sell00000
Strong Sell00000
total44210

In the current month, HNSAN has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. HNSAN average Analyst price target in the past 3 months is ―.

HNSAN Financial Forecast

MXN -6MXN -5MXN -4MXN -3MXN -2Q4 2025Q2 2026Q3 2026
HighMXN -2.49
ConsensusMXN -2.71
LowMXN -2.94

HNSAN Earnings Forecast

Next quarter’s earnings estimate for HNSAN is -MXN 2.71 with a range of -MXN 2.94 to -MXN 2.49. The previous quarter’s EPS was -MXN 4.89. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.

MXN 4.8MMXN 529.9MMXN 1.1BMXN 1.6BMXN 2.1BQ4 2025Q2 2026Q3 2026
HighMXN 2.11B
ConsensusMXN 794M
LowMXN 4.78M

HNSAN Sales Forecast

Next quarter’s sales forecast for HNSAN is MXN 793.61M with a range of MXN 4.78M to MXN 2.11B. The previous quarter’s sales results were MXN 91.95M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

HNSAN Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Hansa Biopharma AB?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Hansa Biopharma AB?
To buy shares of MX:HNSAN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.